drugset / Trial / NCT05630651
The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.
NaSingle-groupOpen-labelTreatment
Summary
A non-randomized, open-label study to evaluate the safety, kinetics and efficacy of a single intravenous infusion of ZS801 in hemophilia B subjects with endogenous FIX ≤2%.
Timeline
- Start
- 2023-04-19
- Primary completion
- 2025-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZS801 | Gene therapy (AAV / viral vector) | 5e+12 vg/kg | Intravenous |